(Q43444374)

23 November 2017

title

IL-2 production by intestinal lamina propria cells in normal inflamed and cancer-bearing colons (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1563100

9 October 2022

author name string

W. E. Pullman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1563100

9 October 2022

W. F. Doe

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1563100

9 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1563100

9 October 2022

publication date

1 April 1992

1 reference

Clinical and Experimental Immunology

23 November 2017

published in

1 reference

23 November 2017

volume

88

1 reference

23 November 2017

issue

1

1 reference

23 November 2017

page(s)

132-137

1 reference

Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin

23 November 2017

cites work

1 reference

12 December 2020

Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease

1 reference

12 December 2020

In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis

1 reference

12 December 2020

The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors.

1 reference

12 December 2020

Regulation of the production and function of granulocytes and monocytes

1 reference

12 December 2020

Differential regulation of colony-stimulating factors and interleukin 2 production by cyclosporin A

1 reference

12 December 2020

The pharmacokinetics of corticosteroid agents

1 reference

12 December 2020

Human intestinal mucosal mononuclear cells exhibit lymphokine-activated killer cell activity

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

12 December 2020

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

1 reference

12 December 2020

The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell responses

1 reference

12 December 2020

Biochemical relationship of thymocyte mitogenic factor and factors enhancing humoral and cell-mediated immune responses

1 reference

12 December 2020

Isolation and functional characterization of human intestinal mucosal lymphoid cells

1 reference

12 December 2020

Intestinal lymphokine-activated killer cells in inflammatory bowel disease

1 reference

12 December 2020

Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity

1 reference

12 December 2020

Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A

1 reference

12 December 2020

Chemotactic activity in inflammatory bowel disease. Role of leukotriene B4.

1 reference

12 December 2020

Inhibition of cytotoxicity by sulfasalazine. I. Sulfasalazine inhibits spontaneous cell-mediated cytotoxicity by peripheral blood and intestinal mononuclear cells from control and inflammatory bowel disease patients

1 reference

12 December 2020

The scavenging of oxidants by sulphasalazine and its metabolites. A possible contribution to their anti-inflammatory effects?

1 reference

12 December 2020

Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens

1 reference

12 December 2020

Lymphocytes isolated from the intestinal lamina propria of normal nonhuman primates have increased expression of genes associated with T-cell activation

1 reference

12 December 2020

Blocking of delivery of the antigen-mediated signal to the nucleus of T cells by cyclosporine

1 reference

12 December 2020

Independent regulation of granulocyte-macrophage colony-stimulating factor and multi-lineage colony-stimulating factor production in T lymphocyte clones

1 reference

12 December 2020

Cyclosporine plasma levels in renal transplant patients. Association with renal toxicity and allograft rejection

1 reference

12 December 2020

Lymphokine-activated and natural killer cell activity in human intestinal mucosa

1 reference

12 December 2020

Cellular origin of interleukin 2 (IL 2) in man: evidence for stimulus-restricted IL 2 production by T4+ and T8+ T lymphocytes

1 reference

12 December 2020

Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA

1 reference

12 December 2020

Isolation and preliminary characterization of human intestinal macrophages

1 reference

12 December 2020

Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease

1 reference

12 December 2020

T cell growth factor: parameters of production and a quantitative microassay for activity

1 reference

12 December 2020

Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapy

1 reference

12 December 2020

10.1111/J.1365-2249.1992.TB03052.X

Identifiers

DOI

1 reference

23 November 2017

0 references

1 reference